Close
AI in Healthcare & Pharma Summit Boston 2026

Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function after Kidney Transplantation

Alexion Pharmaceuticals, Inc. today announced the initiation of dosing in a single, multinational, placebo-controlled clinical trial to evaluate the efficacy and safety of eculizumab...

FDA Approves Use of AFLURIA® Influenza Vaccine with PharmaJet’s Needle-Free Injector

PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza...

Oramed recruits patients to study orally ingestible insulin capsule

Oramed Pharmaceuticals has started recruiting patients for a new clinical trial of ORMD-0801, an orally ingestible insulin capsule, for patients with type 1 diabetes...

OncoGenex Announces Update on Phase 3 ENSPIRIT Trial Evaluating Custirsen in Advanced Non-Small Cell Lung Cancer

OncoGenex Pharmaceuticals, Inc. announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC), is continuing...

Theravance Biopharma to Present at Investor Conferences in September 2014

Theravance Biopharma, Inc. announced today that Rick E Winningham, Theravance Biopharma's Chief Executive Officer, is scheduled to present at the following investor conferences in...

Boehringer enrolls first patients in phase III study to evaluate dabigatran etexilate

Germany-based Boehringer Ingelheim has enrolled the first patients in its new RE-DUAL PCI international phase III study to evaluate dabigatran etexilate in atrial fibrillation...

AstraZeneca announces partnership with Illumina to develop next generation gene sequencing panel for companion diagnostic tests

AstraZeneca today announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing (NGS) platform...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...